Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
Related Posts
Bitcoin Indicator Sounds Buy Alarm For The First Time Since March — Return To $110K Soon?
The price of Bitcoin has struggled around the $95,000 mark after showing some early-weekend strength on Saturday, November 15. According…
XRP Network Activity Hits All-Time High Despite Market Volatility – Bullish Signal?
XRP has broken down from critical support levels, joining the broader crypto market in a wave of selling pressure driven…
XRP Stalls Below Key Resistance, But Setup Aligns For An Elliott Wave Finish
XRP is showing signs of hesitation after a strong rebound, struggling to push past key resistance levels. The recent price…